Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Colorcon
Boehringer Ingelheim
McKinsey
Johnson and Johnson

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Litigation Details for Shire Development LLC v. Cadila Healthcare Limited (D. Del. 2010)

See Plans and Pricing

« Back to Dashboard

Shire Development LLC v. Cadila Healthcare Limited (D. Del. 2010)

Docket   Start Trial Date Filed 2010-07-07
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Kent A. Jordan
Jury Demand None Referred To
Parties CADILA HEALTHCARE LIMITED; COSMO TECHNOLOGIES LIMITED; GIULIANI INTERNATIONAL LIMITED; JOSHUA W. -SM- MARTIN, III; NOGRA PHARMA LIMITED; SHIRE DEVELOPMENT INC.; SHIRE DEVELOPMENT LLC; SHIRE PHARMACEUTICAL DEVELOPMENT INC.; ZYDUS PHARMACEUTICALS (USA) INC.
Patents 6,773,720
Attorneys Andrea L. Wayda; Andrew Wasson; Andy J. Miller; Angus Chen; Caroline Bercier; David A. Bilson; David A. Zwally; David B. Abramowitz; Edgar H. Haug; Elizabeth Murphy; Elizabeth Weiskopf; Erika Selli; Erin A. Lawrence; Frederick L. Cottrell , III; James T. Peterka; Jason A. Lief; Jason James Rawnsley; John C. Phillips , Jr.; Joseph Saphia; Keith D. Parr; Kelly E. Farnan; Mark P. Walters; Megan C. Haney; Michael J. Gaertner; Sandra Kuzmich; Sarah R. Stafford; Wasim K. Bleibel
Firms Benesch Friedlander Coplan & Aronoff LLP; Phillips, Goldman & Spence, P.A.; Phillips, Goldman, McLaughlin & Hall, P.A.; Richards, Layton & Finger, PA
Link to Docket External link to docket
Small Molecule Drugs cited in Shire Development LLC v. Cadila Healthcare Limited
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Shire Development LLC v. Cadila Healthcare Limited (D. Del. 2010)

Date Filed Document No. Description Snippet Link To Document
2012-01-10 133 . Umesh V. Banakar on Invalidity of U.S. Patent No. 6,773,720 by Cadila Healthcare Limited, Zydus Pharmaceuticals… 7 July 2010 1:10-cv-00581 830 Patent None District Court, D. Delaware External link to document
2014-09-16 307 . Umesh V. Banakar on Invalidity of U.S. Patent No. 6,773,720 filed by Cadila Healthcare Limited, Zydus… 16 September 2016 1:10-cv-00581 830 Patent None District Court, D. Delaware External link to document
2014-11-11 327 Umesh V. Banakar on Noninfringement of U.S. Patent No. 6,773,720, Rebuttal Expert Report of Dr. Robert A.… 16 September 2016 1:10-cv-00581 830 Patent None District Court, D. Delaware External link to document
2014-11-11 328 Umesh V. Banakar on Noninfringement of U.S. Patent No. 6,773,720, Rebuttal Expert Report of Dr. Robert A.… 16 September 2016 1:10-cv-00581 830 Patent None District Court, D. Delaware External link to document
2014-11-17 332 and Proposed Claim Constructions for U.S. Patent No. 6,773,720 filed by Cadila Healthcare Limited, Zydus… 16 September 2016 1:10-cv-00581 830 Patent None District Court, D. Delaware External link to document
2015-07-28 391 infringe claims 1 and 3 of U.S. Patent No. 6,773,720 (the “’720 patent”), Which Shire owns The parties…infringement finding Ici. IV. THE ’720 PATENT The ’720 patent concerns controlled~release oral pharmaceutical…appear in claim 1 of the ’720 patent.2 2 Claim l of the ’720 patent reads as follows: l. Controlied-release…limitations from a patent’s specification are not to be read into the claims of the patent Telejlex, Inc. …dispute 9 The ’720 patent does not define the term “melting point” and neither the patent nor the prosecution External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Baxter
Medtronic
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.